Status:
NOT_YET_RECRUITING
Dosage of Early Rehabilitation of ICU Patients
Lead Sponsor:
Medical University of Vienna
Collaborating Sponsors:
European Society of Intensive Care Medicine
Conditions:
Critical Care, Intensive Care
Critical Illness
Eligibility:
All Genders
18+ years
Brief Summary
Rehabilitation already begins in the intensive care unit (ICU) to maintain or restore the functional capacity of ICU patients and to counteract the long-term effects of intensive care treatment. Mobil...
Detailed Description
Intensive care treatment can have long-term effects on patients. Around 40% of intensive care unit (ICU) patients develop an Intensive Care Unit Acquired Weakness (ICUAW), which leads to functional li...
Eligibility Criteria
Inclusion
- Adults (≥ 18 years old) within 48 hours of ICU admission
- Expected to stay \> 24 hours in the ICU
Exclusion
- Patients who receive end-of-life care at the time of screening
- Patients whose treatment plans are still under discussion and/or not all team members are committed to full active treatment
- Patients whose functional status is unlikely to be obtainable
- Patients with language barriers
Key Trial Info
Start Date :
October 1 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 1 2027
Estimated Enrollment :
6000 Patients enrolled
Trial Details
Trial ID
NCT06960642
Start Date
October 1 2025
End Date
June 1 2027
Last Update
May 7 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Medical University of Vienna
Vienna, Vienna, Austria, 1090